<DOC>
	<DOCNO>NCT02891681</DOCNO>
	<brief_summary>To determine accuracy NIR/US assessment tumor vasculature oxygen change predict monitor early neoadjuvant treatment response compare pathological response .</brief_summary>
	<brief_title>Ultrasound Near Infrared Imaging Predicting Monitoring Neoadjuvant Treatment</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Scheduled receive neoadjuvant chemotherapy treatment newly diagnose , locally advanced breast cancer schedule receive neoadjuvant endocrine therapy eventual goal surgery newly diagnose clinical stage IIIII ER+ HER2 breast cancer ( endocrine therapy cohort ) At least 18 year age Female Able understand willing sign IRBapproved write informed consent document Pregnant and/or breastfeed Prior history breast cancer Prior history chest wall radiation Prior history breast reconstruction , reduction , augmentation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>